Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma

International Journal of Gynecological Pathology

Volumn 30, Issue 2, 2011, Pages 145-150

  Meng, Fanling ^a   Luo, Chang ^a   Ma, Lihua ^c   Hu, Yuanlong ^b   Lou, Ge ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Harbin Fifth Hospital   (China)

^c Hulunbuir People' Hospital   (China)

Author keywords

AEG 1; Immunohistochemistry; Ovarian carcinoma; Survival

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTE ELEVATED GENE 1; DISEASE FREE SURVIVAL; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR RECURRENCE;

ADULT; AGED; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL;

EID: 79951775092     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181ffd2f7     Document Type: Article

References (31)

1. Cannistra SA. Cancer of the ovary. N Engl J Med 2004;351: 2519-29.
2. Seidman JD, Kurman RJ. Pathology of ovarian carcinoma. Hematol Oncol Clin North Am 2003;17:909-25, vii. (Pubitemid 37022148)
3. Katso RM, Manek S, Ganjavi H, et al. Overexpression of H-Ryk in epithelial ovarian cancer: prognostic significance of receptor expression. Clin Cancer Res 2000;6:3271-81. (Pubitemid 30637757)
4. Wang Y, Chan DW, Liu VW, et al. Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis. Clin Cancer Res 2010;16: 2529-39.
5. Huang GS, Brouwer-Visser J, Ramirez MJ, et al. Insulin-like growth factor 2 (IGF2) expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer. Clin Cancer Res 2010;16:2999-3010.
6. Yang GF, He WP, Cai MY, et al. Intensive expression of Bmi- 1 is a new independent predictor of poor outcome in patients with ovarian carcinoma. BMC Cancer 2010;10:133.
7. Kaji M, Kabir-Salmani M, Anzai N, et al. Properties of L-type amino acid transporter 1 in epidermal ovarian cancer. Int J Gynecol Cancer 2010;20:329-36.
8. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47. (Pubitemid 34110469)
9. Li J, Zhang N, Song LB, et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 2008;14:3319-26.
10. Liu L, Wu J, Ying Z, et al. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res 2010;70:3750-9.
11. Song L, Li W, Zhang H, et al. Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. J Pathol 2009; 219:317-26.
12. Ash SC, Yang DQ, Britt DE. LYRIC/AEG-1 overexpression modulates BCCIPalpha protein levels in prostate tumor cells. Biochem Biophys Res Commun 2008;371:333-8.
13. Jian-Bo X, Hui W, Yu-Long H, et al. Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol 2010.
14. Yu C, Chen K, Zheng H, et al. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 2009;30:894-901.
15. Emdad L, Sarkar D, Su ZZ, et al. Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther 2007;114: 155-70. (Pubitemid 46561534)
16. Yoo BK, Gredler R, Vozhilla N, et al. Identification of genes conferring resistance to 5-fluorouracil. Proc Natl Acad Sci U S A 2009;106:12938-43.
17. Silverberg SG. Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol 2000;19:7-15. (Pubitemid 30010638)
18. Xia Z, Zhang N, Jin H, et al. Clinical significance of astrocyte elevated gene-1 expression in human oligodendrogliomas. Clin Neurol Neurosurg 2010;112:413-9.
19. Yoo BK, Emdad L, Su ZZ, et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 2009;119:465-77.
20. Sarkar D, Emdad L, Lee SG, et al. Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes. Cancer Res 2009;69:8529-35.
21. Hu G, Wei Y, Kang Y. The multifaceted role of MTDH/ AEG-1 in cancer progression. Clin Cancer Res 2009;15:5615-20.
22. Emdad L, Lee SG, Su ZZ, et al. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci U S A 2009;106:21300-5.
23. Lee SG, Su ZZ, Emdad L, et al. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci U S A 2006;103:17390-5. (Pubitemid 44788979)
24. Lee SG, Su ZZ, Emdad L, et al. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 2008;27:1114-21. (Pubitemid 351253177)
25. Sarkar D, Park ES, Emdad L, et al. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res 2008;68:1478-84. (Pubitemid 351346856)
26. Thirkettle HJ, Mills IG, Whitaker HC, et al. Nuclear LYRIC/ AEG-1 interacts with PLZF and relieves PLZF-mediated repression. Oncogene 2009;28:3663-70.
27. Li J, Yang L, Song L, et al. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene 2009;28:3188-96.
28. Emdad L, Sarkar D, Lee SG, et al. Astrocyte elevated gene-1: a novel target for human glioma therapy. Mol Cancer Ther 2010; 9:79-88.
29. Hu G, Chong RA, Yang Q, et al. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 2009;15: 9-20.
30. Liu H, Song X, Liu C, et al. Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. J Exp Clin Cancer Res 2009;28:19.
31. Yoo BK, Chen D, Su ZZ, et al. Molecular mechanism of chemoresistance by astrocyte elevated gene-1. Cancer Res 2010;70:3249-58.